MeiraGTx names biotech, pharmaceuticals analyst as CFO
Perspectivas América Latina 2023 Emerging Trends & Growth
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
MeiraGTx Holdings PLC has appointed Katherine Breedis as CFO.
Breedis was previously managing director of equity research and senior analyst for biotechnology and major pharmaceuticals at Stifel Nicolaus & Co. Inc.
New York-based MeiraGTx develops treatments for inherited and acquired disorders.
